Evren Alici is the Head of Scientific Advisory Board at Fuse Biotherapeutics. He is also the Head of Cell and Gene Therapy Group at Karolinska Institutet as well as the CEO & Chairman at Vycellix inc.
Evren holds a PhD in Hematology from Karolinska Institutet.